Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what impact assessment his Department has conducted on the potential cost of eliminating or reducing prescription charges for people with long-term medical conditions.

The Department receives numerous representations on prescription charges for people in England with long-term medical conditions. It is not possible to say how many of these were from clinical experts or health economists, though the independent Commission on the Future of Health and Social Care in England’s report, A new settlement for health and social care, published in 2014, did have health economist input. There have also been representations from the Prescription Charges Coalition, but it is not certain to what extent these were informed by clinical experts or health economists.

Arrangements are in place to ensure that prescriptions are affordable for everyone, including those with a long-term condition. There are exemptions from the prescription charge for people with low income, including through receipt of specific benefits and through application to the NHS Low Income Scheme. For those who do not qualify for exemption, prescription prepayment certificates are also available, which allow people to claim as many prescriptions as they need for a set cost. To support those with high levels of need, the cost of the 12-month and 3-month certificates have been frozen since 2009 and 2011, respectively.

The Department has not undertaken a formal impact assessment on the potential cost of eliminating or reducing prescription charges for people with long-term medical conditions. However, the Prescription Charges Review undertaken by Professor Sir Ian Gilmore, and published in 2010, estimated that extending exemption to all those with a long-term condition would lead to a loss in revenue of between £360 and £430 million.